Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03071211 · ClinicalTrials.gov registry record · NA

Catheter Management After Pelvic Reconstructive Surgery

A NA study, sponsored by Hartford Hospital.

Completed
Registry status
NA
Development phase
96
Enrollment target

NCT03071211: Completed NA study, sponsored by Hartford Hospital.

NCT03071211 is a NA study that has completed, run by Hartford Hospital. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03071211, a NA study, has completed, sponsored by Hartford Hospital.

COMPLETED
Registry status
NA
Development phase
96 participants
Enrollment target

Study Summary

This is a randomized controlled trial comparing plug-unplug catheter management, continuous drainage catheter systems and patients that do not get discharged with catheters after inpatient pelvic reconstructive surgery.

Primary Outcome

Participants complete this 18-question survey preoperatively and 3-5 days postoperatively.

Interventions

  • DEVICE Plug-unplug catheter management
  • DEVICE Continuous drainage catheter management

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2017-02-26
Est. Completion 2019-01-31
Phase NA
Hartford Hospital

75 total trials

What the finished NCT03071211 record still lists

NCT03071211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Plug-unplug catheter management is the first listed.

NCT03071211 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03071211 about?

NCT03071211 is a clinical study titled "Catheter Management After Pelvic Reconstructive Surgery". This is a randomized controlled trial comparing plug-unplug catheter management, continuous drainage catheter systems and patients that do not get discharged with catheters after inpatient pelvic reconstructive surgery.

What is the current status of trial NCT03071211?

This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2017-02-26. Estimated completion is 2019-01-31.

What interventions are being tested in trial NCT03071211?

The interventions under investigation include: Plug-unplug catheter management (DEVICE), Continuous drainage catheter management (DEVICE).

Who is sponsoring clinical trial NCT03071211?

This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03071211's enrollment target sits among peer trials

96 925th of 2000 higher than 1,070 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03401762 · 96 participants · NA

    Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke

  • NCT03471260 · 96 participants · Phase 1

    Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

  • NCT03549559 · 96 participants · NA

    Imaging Histone Deacetylase in the Heart

  • NCT03841058 · 96 participants · Phase 2

    Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03071211, the US trial registry maintained by the National Library of Medicine. NCT03071211 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.